ADMA BIOLOGICS, INC. Amortization of Debt Issuance Costs
ADMA BIOLOGICS, INC. (ADMA) reported Amortization of Debt Issuance Costs of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2017-02-24
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for the quarter ending 2016-12-31 was $0.00.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for the quarter ending 2016-09-30 was $0.00.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for fiscal 2015 was $39.72K, a 68.42% decline from fiscal 2014.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for fiscal 2014 was $125.78K, a 26.74% increase from fiscal 2013.
- ADMA BIOLOGICS, INC. amortization of debt issuance costs for fiscal 2013 was $99.24K, a 3653.33% increase from fiscal 2012.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $0.00 10-K · filed 2017-02-24 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $0.00 derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $16.35K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $16.35K derived: sum of 3 quarters · filed 2017-02-24 | $39.72K 10-K · filed 2017-02-24 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $16.35K derived: sum of 2 quarters · filed 2016-11-10 | $39.72K 10-Q · filed 2016-11-10 | $71.24K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $16.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $39.72K 10-Q · filed 2016-08-12 | $71.24K derived: sum of 3 quarters · filed 2016-08-12 | $104.42K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $23.36K 10-Q · filed 2016-05-13 | $54.88K derived: sum of 2 quarters · filed 2016-05-13 | $88.07K derived: sum of 3 quarters · filed 2016-05-13 | $119.59K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $31.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $64.71K derived: sum of 2 quarters · filed 2016-03-23 | $96.22K derived: sum of 3 quarters · filed 2016-03-23 | $125.78K 10-K · filed 2016-03-23 |
| 2014-09-30 | $33.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $64.70K derived: sum of 2 quarters · filed 2015-11-10 | $94.26K 10-Q · filed 2015-11-10 | $121.45K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $31.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $61.07K 10-Q · filed 2015-08-11 | $88.27K derived: sum of 3 quarters · filed 2015-08-11 | $114.54K derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | $29.55K 10-Q · filed 2015-05-12 | $56.75K derived: sum of 2 quarters · filed 2015-05-12 | $83.03K derived: sum of 3 quarters · filed 2015-05-12 | $108.15K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $27.20K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $53.47K derived: sum of 2 quarters · filed 2015-03-09 | $78.60K derived: sum of 3 quarters · filed 2015-03-09 | $99.24K 10-K · filed 2015-03-09 |
| 2013-09-30 | $26.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $51.40K derived: sum of 2 quarters · filed 2014-11-10 | $72.04K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $25.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $45.76K 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $20.64K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $2.64K 10-K · filed 2014-03-28 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |